These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 19051137
1. Design of potent GlyT1 inhibitors: in vitro and in vivo profiles. Bridges TM, Williams R, Lindsley CW. Curr Opin Mol Ther; 2008 Dec; 10(6):591-601. PubMed ID: 19051137 [Abstract] [Full Text] [Related]
2. Inhibitors of GlyT1 affect glycine transport via discrete binding sites. Mezler M, Hornberger W, Mueller R, Schmidt M, Amberg W, Braje W, Ochse M, Schoemaker H, Behl B. Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213 [Abstract] [Full Text] [Related]
11. Recent progress in the discovery of non-sarcosine based GlyT1 inhibitors. Wolkenberg SE, Sur C. Curr Top Med Chem; 2010 Nov; 10(2):170-86. PubMed ID: 20166956 [Abstract] [Full Text] [Related]
13. Design, synthesis, and in vivo efficacy of glycine transporter-1 (GlyT1) inhibitors derived from a series of [4-phenyl-1-(propylsulfonyl)piperidin-4-yl]methyl benzamides. Lindsley CW, Zhao Z, Leister WH, O'Brien J, Lemaire W, Williams DL, Chen TB, Chang RS, Burno M, Jacobson MA, Sur C, Kinney GG, Pettibone DJ, Tiller PR, Smith S, Tsou NN, Duggan ME, Conn PJ, Hartman GD. ChemMedChem; 2006 Aug; 1(8):807-11. PubMed ID: 16902933 [No Abstract] [Full Text] [Related]
14. The effects of glycine transporter I inhibitor, N-methylglycine (sarcosine), on ketamine-induced alterations in sensorimotor gating and regional brain c-Fos expression in rats. Yang SY, Hong CJ, Huang YH, Tsai SJ. Neurosci Lett; 2010 Jan 18; 469(1):127-30. PubMed ID: 19944746 [Abstract] [Full Text] [Related]
15. Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia. Yang CR, Svensson KA. Pharmacol Ther; 2008 Dec 18; 120(3):317-32. PubMed ID: 18805436 [Abstract] [Full Text] [Related]
17. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia. Tsai G, Lane HY, Yang P, Chong MY, Lange N. Biol Psychiatry; 2004 Mar 01; 55(5):452-6. PubMed ID: 15023571 [Abstract] [Full Text] [Related]
18. Glycine transporter-1: a new potential therapeutic target for schizophrenia. Hashimoto K. Curr Pharm Des; 2011 Mar 01; 17(2):112-20. PubMed ID: 21355838 [Abstract] [Full Text] [Related]
20. Inhibition of system A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action. Javitt DC, Duncan L, Balla A, Sershen H. Mol Psychiatry; 2005 Mar 01; 10(3):275-87. PubMed ID: 15278098 [Abstract] [Full Text] [Related] Page: [Next] [New Search]